The Biologics and Biosimilars Congress: Asia 2018 is dedicated to monoclonal antibody, recombinant protein, antibody-drug conjugates (ADCs), vaccine R&D and commercialisation.
The Biologics and Biosimilars Congress: Asia 2018 covers topics such as:
Immunotherapy
Antibody-based therapeutics & engineering
Antibody-drug conjugates(ADCs)
Protein biotherapeutics
Vaccine R&D and commercialisation
Monoclonal antibody (Mab) and antibody-derived therapeutics for chronic diseases
Past Events
Biologics and Biosimilars Congress: Asia 2018 - 27-28 Nov 2018, Singapore (78474)
Important
Please, check "Biologics and Biosimilars Congress: Asia" official website for possible changes, before making any traveling arrangements